This evaluation will handle the freshly investigated therapeutic medicine, and the outcome of clinical trials that goal to cure HBV.Sulfhydryl alkylating agent that inactivates NADP-dependent isocitrate dehydrogenase and lots of endonucleases.Augments currents from indigenous M-channels in sympathetic neurons and functions being an opener for KCNQ2